Towards Healthcare
APAC Biotechnology Market to Rise at 14.80% CAGR till 2034

APAC Biotechnology Market Accelerates with New Investments

Projections indicate that, the APAC biotechnology market will increase from USD 372.23 billion in 2024 to USD 1611.67 billion by 2034, experiencing a CAGR of 14.80% over the next 10 years. The APAC biotechnology market is growing due to rising government initiatives in the region.

  • Insight Code: 6280
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

FAQ's

The APAC biotechnology market currently in 2025 records USD 432.72 billion and is anticipated to grow to USD 1611.67 billion by 2034, advancing at a CAGR of 14.80% from 2024 to 2034.

China is currently leading the APAC biotechnology market share 35% due to rising R&D and government initiatives.

Some key players include WuXi AppTec, WuXi Biologics, BeiGene, Innovent Biologics, Celltrion, etc.

Key trends include rising focus on genomics, demand for biologics, and rising product of vaccines.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, WHO, PIB, IBEF.